ARS Pharmaceuticals (SPRY) Depreciation And Amortization

SPRY Annual D&A

-$6.80 M
-$7.12 M-2233.23%

31 December 2023

SPRY Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SPRY Quarterly D&A

-$1.80 M
+$81.00 K+4.29%

30 September 2024

SPRY Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SPRY TTM D&A

-$7.41 M
-$266.00 K-3.73%

30 September 2024

SPRY TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SPRY Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-2233.2%+4.3%-3.7%
3 y3 years-10000.0%+4.3%-3.7%
5 y5 years-10000.0%+4.3%-3.7%

SPRY Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-2233.2%at low-703.7%+8.3%-2421.3%at low
5 y5-year-2233.2%at low-703.7%+8.3%-2421.3%at low
alltimeall time-2233.2%at low-703.7%+8.3%-2421.3%at low

ARS Pharmaceuticals Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sept 2024
-
-$1.80 M(-4.3%)
-$7.41 M(+3.7%)
June 2024
-
-$1.89 M(-4.2%)
-$7.14 M(+2.2%)
Mar 2024
-
-$1.97 M(+12.8%)
-$6.99 M(+2.6%)
Dec 2023
-$6.80 M
-$1.75 M(+13.4%)
-$6.80 M(+42.9%)
Sept 2023
-
-$1.54 M(-11.1%)
-$4.76 M(+48.1%)
June 2023
-
-$1.73 M(-3.2%)
-$3.21 M(+111.5%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$1.79 M(-698.3%)
-$1.52 M(-576.5%)
Dec 2022
$319.00 K(+49.8%)
$299.00 K(+4171.4%)
$319.00 K(+1495.0%)
Sept 2022
-
$7000.00(-118.9%)
$20.00 K(+53.8%)
June 2022
-
-$37.00 K(-174.0%)
$13.00 K(-74.0%)
Mar 2022
-
$50.00 K
$50.00 K
Dec 2021
$213.00 K(+3450.0%)
-
-
Dec 2020
$6000.00
-
-

FAQ

  • What is ARS Pharmaceuticals annual depreciation & amortization?
  • What is the all time high annual D&A for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals annual D&A year-on-year change?
  • What is ARS Pharmaceuticals quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals quarterly D&A year-on-year change?
  • What is ARS Pharmaceuticals TTM depreciation & amortization?
  • What is the all time high TTM D&A for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals TTM D&A year-on-year change?

What is ARS Pharmaceuticals annual depreciation & amortization?

The current annual D&A of SPRY is -$6.80 M

What is the all time high annual D&A for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high annual depreciation & amortization is $319.00 K

What is ARS Pharmaceuticals annual D&A year-on-year change?

Over the past year, SPRY annual depreciation & amortization has changed by -$7.12 M (-2233.23%)

What is ARS Pharmaceuticals quarterly depreciation & amortization?

The current quarterly D&A of SPRY is -$1.80 M

What is the all time high quarterly D&A for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high quarterly depreciation & amortization is $299.00 K

What is ARS Pharmaceuticals quarterly D&A year-on-year change?

Over the past year, SPRY quarterly depreciation & amortization has changed by +$81.00 K (+4.29%)

What is ARS Pharmaceuticals TTM depreciation & amortization?

The current TTM D&A of SPRY is -$7.41 M

What is the all time high TTM D&A for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high TTM depreciation & amortization is $319.00 K

What is ARS Pharmaceuticals TTM D&A year-on-year change?

Over the past year, SPRY TTM depreciation & amortization has changed by -$266.00 K (-3.73%)